Table 1 Indication for antiocoagulant therapy and distribution of differente DOAC among patients.
From: Management of ongoing direct anticoagulant treatment in patients with hip fracture
Indication for anticoagulation | n | % |
|---|---|---|
Atrial fibrillation | 68 | 91 |
Venous thromboembolism | 5 | 7 |
Other | 1 | 2 |
DOA | ||
Dabigatran | 28 | 38 |
Rivaroxaban | 19 | 26 |
Apixaban | 24 | 32 |
Edoxaban | 3 | 4 |